Soligenix to present at the thinkequity conference

Princeton, n.j. , oct. 16, 2023 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the company will deliver a corporate presentation at the upcoming thinkequity conference.
SNGX Ratings Summary
SNGX Quant Ranking